Next Article in Journal
The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
Previous Article in Journal
Neoadjuvant Immunotherapy Combined with Chemotherapy for Local Advanced Non-Small-Cell Lung Cancer in a Patient with a History of Breast Cancer: A Case Report
 
 
Review

Diagnostic and Therapeutic Indications for Endoscopic Ultrasound (EUS) in Patients with Pancreatic and Biliary Disease—Novel Interventional Procedures

1
Department of Surgery, Hietzing Clinic, Vienna Hospital Association (WIGEV), 1130 Vienna, Austria
2
Department of Medicine I, Endoscopy, Wiener Neustadt Hospital, 2700 Wiener Neustadt, Austria
3
ScienceCenter Donaustadt, 1220 Vienna, Austria
4
Gastroenterology and Oncology Clinics of Donaustadt and Floridsdorf, Vienna Hospital Association (WIGEV), 1220 Vienna, Austria
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2022, 29(9), 6211-6225; https://doi.org/10.3390/curroncol29090488
Received: 28 July 2022 / Revised: 22 August 2022 / Accepted: 24 August 2022 / Published: 29 August 2022
There is growing evidence supporting the substantial, essential and indispensable role of endoscopic ultrasound (EUS) as a key diagnostic armamentarium for upper GI oncologic surgery. Well described in countless publications, EUS holds that position in gastroenterological expert centers all over Europe. Despite its undisputable contributions to oncologic upper GI surgery, the availability of this technique at the expert level shows up in an irregular spread pattern. Endoscopic ultrasound’s primary use during the first few years after its creation was the detection of pancreatic cancer. From then on, EUS developed in different directions, becoming a diagnostic tool that increasingly better defines its status as a method of minimally invasive therapeutic applications and a useful addition to surgical options. As a result, several surgical interventions could even be replaced by ultrasound-targeted interventions. This process took place in just a few years and was made possible by technical development that sensibly combined high-resolution ultrasound with therapeutic endoscopy. The present article will serve to cover the most prevalent uses with supporting data considering the growing list of suggested indications for EUS while also examining cutting-edge initiatives that might soon become the standard of clinical practice. Endoscopic centers with high expertise are needed to train future experts in the growing field of EUS interventions. View Full-Text
Keywords: endoscopic ultrasound (EUS); pancreatic cancer; cancer surgery; pancreatic cysts; EUS-targeted biopsy endoscopic ultrasound (EUS); pancreatic cancer; cancer surgery; pancreatic cysts; EUS-targeted biopsy
MDPI and ACS Style

Prager, M.; Prager, E.; Sebesta, C., Jr.; Sebesta, C. Diagnostic and Therapeutic Indications for Endoscopic Ultrasound (EUS) in Patients with Pancreatic and Biliary Disease—Novel Interventional Procedures. Curr. Oncol. 2022, 29, 6211-6225. https://doi.org/10.3390/curroncol29090488

AMA Style

Prager M, Prager E, Sebesta C Jr., Sebesta C. Diagnostic and Therapeutic Indications for Endoscopic Ultrasound (EUS) in Patients with Pancreatic and Biliary Disease—Novel Interventional Procedures. Current Oncology. 2022; 29(9):6211-6225. https://doi.org/10.3390/curroncol29090488

Chicago/Turabian Style

Prager, Manfred, Elfi Prager, Christian Sebesta Jr., and Christian Sebesta. 2022. "Diagnostic and Therapeutic Indications for Endoscopic Ultrasound (EUS) in Patients with Pancreatic and Biliary Disease—Novel Interventional Procedures" Current Oncology 29, no. 9: 6211-6225. https://doi.org/10.3390/curroncol29090488

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop